Sprott’s Lucid Diagnostics LUCD Stock Holding History
Bought
Maintained
Sold
Other funds holding LUCD
Sprott's LUCD Position: Q3 2026 in Review
Sprott sold out of Lucid Diagnostics (LUCD) in Q3 2026, closing a stake of 20,000 shares — an estimated $21.4K sold.
Sprott first reported a position in LUCD in Q3 2025 and held it in 4 quarters. The position peaked at $25.2K in Q3 2025. 82 funds tracked by Wall St. Rank hold LUCD as of Q3 2026.
- Sprott reported no remaining Lucid Diagnostics position as of Q3 2026 after selling out during the quarter.
- Sprott sold 20,000 Lucid Diagnostics shares in Q3 2026, an estimated $21.4K.
- Sprott first reported a position in Lucid Diagnostics in Q3 2025 and held it in 4 quarters.
- Sprott's Lucid Diagnostics position peaked at $25.2K in Q3 2025.
- 82 funds tracked by Wall St. Rank held Lucid Diagnostics as of Q3 2026.
Based on Sprott's 13F filing for Q3 2026, filed 9 Nov 2026.